Proliferation arrest is the dominant and most obvious effect of EZH2 inhibitors or EZH2 shRNA in GCB type DLBCL cells, regardless of whether EZH2 is wild type or affected by gain of function mutation7. The gene discussed is EZH2; the disease is diffuse large B-cell lymphoma.